Skip to main content

Table 1 Patients’ characteristics

From: Low Ten-eleven-translocation 2 (TET2) transcript level is independent of TET2 mutation in patients with myeloid neoplasms

Patients

Number

MDS

10

 Gender

  Male/Female

5/5

 Age (years), median (range):

58 (28–78)

  WHO 2008

 

  RA

2

  RARS

1

  RCMD

4

  RAEB-1

3

  IPSS-R

 

  Low

5

  Intermediate

2

  High

1

  Not available

2

 Cytogenetics

  Normal karyotype

10

 BM blast (%)

  <5 %

7

  ≥5 and <10 %

3

AML

9

 Gender

  Male/Female

4/5

 Age (years), median (range)

66 (44–90)

 BM blasts (%), median (range)

92 (31–98.5)

 Cytogenetics

  Normal karyotype

2

  Deletion 5q

1

  Monosomy 7

1

  Complex karyotype

1

  No growth

4

  1. Abbreviations: MDS myelodysplastic syndromes, WHO World Health Organization, RA refractory anemia, RARS refractory anemia with ringed sideroblasts, del(5q) MDS with isolated del(5q), RCMD refractory cytopenia with multilineage dysplasia, RAEB-1 refractory anemia with excess blast-1, BM bone marrow, IPSS-R Revised International Prognostic Scoring System, AML acute myeloid leukemia